Professor Jonathan Sprent, FRS, is an Australian immunologist. His research has focused on the formation and activation of T cell leukocytes, and methods to overcome T cell-mediated rejection of transplanted tissue.[1]
Jonathan Sprent FRS | |
|---|---|
| Nationality | Australian |
| Alma mater | Walter and Eliza Hall Institute |
| Known for | T cells |
| Awards | Taylor Prize (1995) AAI Lifetime Achievement Award (2005) |
| Scientific career | |
| Fields | immunology |
| Institutions | Garvan Institute of Medical Research |
| Doctoral advisor | Jacques Miller |
Awards
edit- 1995: J. Allyn Taylor International Prize in Medicine
- 1998: Fellow of the Royal Society[1]
- 2003: Errol Solomon Meyers Memorial Lecture
- 2006: Fellow of the Australian Academy of Science
- 2015: American Association of Immunologists Lifetime Achievement Award[2]
- 2017: National Academy of Sciences (Immunology)
He is an honorary member of the British Society for Immunology.[3]
References
edit- ^ a b "Jonathan Sprent". Royal Society. 12 August 2015. Retrieved 14 August 2018.
- ^ "Professor Jonathan Sprent to receive AAI Lifetime Achievement Award". EurekAlert!. 21 January 2015. Retrieved 19 September 2018.
- ^ "Honorary members". British Society for Immunology. Retrieved 9 October 2018.
.svg){kind=small}   | This article about an Australian scientist is a stub. You can help Wikipedia by expanding it. |